Adaptive Biotechnologies
Organization
Adaptive Biotechnologies is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. The company utilizes its proprietary immune profiling platform to read and translate genetic code, developing personalized diagnostics and therapeutics for cancer, autoimmune conditions, and infectious diseases.
What experts have said about Adaptive Biotechnologies
1 statement · 1 negative
Adaptive Biotechnologies shares fell about 6.4% aftermarket.
“shares are down about 6, 6.4% right now.”
Open the episode · SpaceX Jumps, Adaptive Biotechnologies Slides, Dave & Buster's LowerListen at 3:29
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
